Saikosaponin A (Compound 12), a triterpenoid glycoside isolated from Bupleurum falcatum L., has been investigated for its potential to overcome radioresistance in GC by targeting the PERK-ATF4-CHOP pathway within the ER. This evidence concerns the gene DDIT3 and gastric cancer.